Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Feasibility and Safety of Walking Football in Patients With Type 2 Diabetes

20. august 2019 opdateret af: Romeu Mendes, Universidade do Porto
Our main challenge is to develop a novel physical activity intervention to promote exercise participation sustainability and effective health benefits in type 2 diabetes (T2D) population with minimum health risks. The relevance of this study is supported by four cornerstones: 1) The Portuguese love football and there seems to be a major potential in the implementation of football practice as part of the prevention and treatment of noncommunicable diseases for the middle-aged and elderly Portuguese population; 2) no studies have assessed the feasibility and safety of a walking football exercise program for middle-age and older patients with T2D; 3) the proposed investigation relies on robust methodology; 4) this intervention can have further sustainability with the enrollment of football clubs and primary health care units.

Studieoversigt

Status

Afsluttet

Detaljeret beskrivelse

This work will be a quasi-experimental study where we aim to test the feasibility and safety of walking football in patients with T2D. The recruitment of participants will be held in primary health care units by Family Medicine medical doctors. All participants will receive instructions to maintain daily-life routines (lifestyle-related physical activity and dietary pattern), and to continue with usual care (diabetes consultations on primary health care units and pharmacological regimen) along the studies duration. All participants will receive basic sports material (sports bag, T-shirt, and sports shoes). Participants will be organized in two teams of 20 players. Each team will have 60-min walking football exercise sessions three times per week (non-consecutive days), during three months (36 sessions). Different walking football exercise strategies will be developed according to participants' motor skills and tested with dose-escalated intensity for its safety (acute effects on capillary glycaemia, blood pressure, foot impact, exercise-related injuries and adverse events) and enjoyment. Exercise intensity will range between light to vigorous. No submaximal or maximal exercises will be tested. Cumulative short-term effects will also be analyzed along the three months through pre- and post-study evaluations. Exercise sessions will be conducted on a sports hall (indoor court) by a football coach and supervised by an exercise physiologist and a nurse.

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

40

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

      • Porto, Portugal, 4050-600
        • Instituto de Saúde Pública da Universidade do Porto

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

50 år til 70 år (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Han

Beskrivelse

Inclusion Criteria:

  • diagnosis of type 2 diabetes for at least 12 months;
  • glycated hemoglobin bellow 10 %;
  • not having started insulin therapy in the previous six months;
  • not having started therapy with sulfonylureas in the previous six months;
  • major complications of diabetes screened and controlled (diabetic retinopathy, diabetic nephropathy and diabetic foot);
  • no symptoms of coronary artery disease;
  • no cardiovascular, respiratory and musculoskeletal contraindications to exercise;
  • not under cancer treatment (radiotherapy or intravenous chemotherapy);
  • without limitations in gait or balance;
  • independent living in the community;
  • not engaged in supervised exercise;
  • non-smokers at least for 6 months.

Exclusion Criteria:

  • cardiological stress test with cardiac or hemodynamic problems

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: N/A
  • Interventionel model: Enkelt gruppeopgave
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Exercise
Walking football exercise program
Participants will be organized in two teams of 20 players. Each team will have 60-min walking football exercise sessions three times per week (non-consecutive days), during three months (36 sessions). Different walking football exercise strategies will be developed according to participants' motor skills and tested with dose-escalated intensity for its safety and enjoyment. Exercise intensity will range between light to vigorous. No submaximal or maximal exercises will be tested. Exercise sessions will be conducted on a sports hall (indoor court) by a football coach and supervised by an exercise physiologist and a nurse.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Exercise intensity - subjective internal load
Tidsramme: Through 3 months
OMNI rating of perceived exertion scale during exercise (0 [lowest] to 10 [highest] points)
Through 3 months
Exercise intensity - objective internal load
Tidsramme: Through 3 months
Heart rate during exercise
Through 3 months
Exercise intensity - external load
Tidsramme: Through 3 months
Distance (km) assessed using GPS tracking during exercise
Through 3 months
Acute glycemic effect
Tidsramme: Change between before and immediately after each exercise session
Acute change in capillary blood glucose with exercise sessions
Change between before and immediately after each exercise session
Acute systolic blood pressure effect
Tidsramme: Change between before and immediately after each exercise session
Acute change in systolic blood pressure with exercise sessions
Change between before and immediately after each exercise session
Acute diastolic blood pressure effect
Tidsramme: Change between before and immediately after each exercise session
Acute change in diastolic blood pressure with exercise sessions
Change between before and immediately after each exercise session
Incidence of falls
Tidsramme: Through 3 months
Number of falls during the exercise program
Through 3 months
Incidence of foot injuries
Tidsramme: Through 3 months
Number of reported foot injuries during the exercise program
Through 3 months
Incidence of musculoskeletal injuries
Tidsramme: Through 3 months
Number of reported musculoskeletal injuries during the exercise program
Through 3 months
Rate of Enjoyment
Tidsramme: Through 3 months
Self-reported exercise sessions' enjoyment on a likert scale (1 [lowest] to 5 [highest] points)
Through 3 months

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Glycemic control
Tidsramme: Change from baseline to 3 months
Glycated hemoglobin (venous blood analysis)
Change from baseline to 3 months
Blood lipid profile
Tidsramme: Change from baseline to 3 months
Total cholesterol (venous blood analysis)
Change from baseline to 3 months
Clinical systolic blood pressure
Tidsramme: Change from baseline to 3 months
Resting systolic blood pressure
Change from baseline to 3 months
Clinical diastolic blood pressure
Tidsramme: Change from baseline to 3 months
Resting diastolic blood pressure
Change from baseline to 3 months
Body mass index
Tidsramme: Change from baseline to 3 months
Body mass index
Change from baseline to 3 months
Waist circumference
Tidsramme: Change from baseline to 3 months
Waist circumference
Change from baseline to 3 months
Body fat
Tidsramme: Change from baseline to 3 months
Body fat (bioelectrical impedance analysis)
Change from baseline to 3 months
Body lean mass
Tidsramme: Change from baseline to 3 months
Body lean mass (bioelectrical impedance analysis)
Change from baseline to 3 months
Agility/balance
Tidsramme: Change from baseline to 3 months
Timed Up and Go Test
Change from baseline to 3 months
Habitual physical activity
Tidsramme: Change from baseline to 3 months
Global Physical Activity Questionnaire
Change from baseline to 3 months
Food pattern
Tidsramme: Change from baseline to 3 months
24h-food recall analysis
Change from baseline to 3 months
Cognitive state
Tidsramme: Change from baseline to 3 months
Montreal Cognitive Assessment score (0 [lowest] to 30 [highest] points)
Change from baseline to 3 months
Health-related quality of life
Tidsramme: Change from baseline to 3 months
EQ-5D-5L questionnaire score (0 [lowest] to 100 [highest] points)
Change from baseline to 3 months
Medication
Tidsramme: Change from baseline to 3 months
Number of medications
Change from baseline to 3 months

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Romeu Mendes, MD, PhD, EPIUnit - Instituto de Saúde Pública, Universidade do Porto

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Generelle publikationer

  • Barbosa A, Brito J, Costa J, Ramos E, Firmino-Machado J, Seabra A, Figueiredo P, Sá MJ, Lunet N, Mendes R. SWEET-FOOTBALL: Development of an evidence-based walking football program for middle-aged and older patients with type 2 diabetes. Football is Medicine Conference 2019 - Programme and Abstracts. Odense: University of Southern Denmark; 2019. p. 32.
  • Barbosa A, Brito J, Sá MJ, Puga F, Firmino-Machado J, Seabra A, Figueiredo P, Ramos E, Lunet N, Mendes R. Adherence and enjoyment of a walking-football program for patients with type 2 diabetes: SWEET-FOOTBALL Project. In: Bunc V, Tsolakidis E, editors. Book of Abstracts of the 24th Annual Congress of the European College of Sport Science. Prague: ECSS; 2019. p. 120-1.
  • Rago V, Brito J, Costa J, Barbosa A, Figueiredo P, Seabra A, Travassos B, Mendes R. Activity profile during walking football training sessions in patients with type 2 diabetes. Football is Medicine Conference 2019 - Programme and Abstracts. Odense: University of Southern University; 2019. p. 41.
  • Costa J, Brito J, Barbosa A, Figueiredo P, Seabra A, Sá MJ, Firmino-Machado J, Ramos E, Mendes R. Nocturnal cardiac autonomic activity in patients with type 2 diabetes engaged in a walking football programme. Football is Medicine Conference 2019 - Programme and Abstracts. Odense: University of Southern Denmark; 2019. p. 39.
  • Barbosa A, Brito J, Costa J, Figueiredo P, Seabra A, Mendes R. Feasibility and safety of a walking football program in middle-aged and older men with type 2 diabetes. Prog Cardiovasc Dis. 2020 Nov-Dec;63(6):786-791. doi: 10.1016/j.pcad.2020.06.014. Epub 2020 Jul 4.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

17. september 2018

Primær færdiggørelse (Faktiske)

31. januar 2019

Studieafslutning (Faktiske)

30. juni 2019

Datoer for studieregistrering

Først indsendt

10. januar 2019

Først indsendt, der opfyldte QC-kriterier

16. januar 2019

Først opslået (Faktiske)

22. januar 2019

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

22. august 2019

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

20. august 2019

Sidst verificeret

1. august 2019

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner